SCHEMBL6034154

SCHEMBL6034154

Cc1ccc(S(=O)(=O)[O-])cc1.[I+]

nearest known ligand 0.62

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.62
CA1 P00915 4/20 0.56
CA2 P00918 4/20 0.56
CA12 O43570 2/20 0.56
CA9 Q16790 2/20 0.56
CA3 P07451 1/20 0.56
CA6 P23280 1/20 0.56
CA5A P35218 1/20 0.56
CA7 P43166 1/20 0.56
CA5B Q9Y2D0 1/20 0.56
TLR9 Q9NR96 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 4/20 0.50
TDP1 Q9NUW8 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP9 P14780 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL30420977 0.97 GAA (0.59) GAACA1CA2CA12CA9
SCHEMBL3180420 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL10663598 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL8943267 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL8617002 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL2138368 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL6917586 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL22615914 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL20583857 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL11815250 0.94 GAA (0.62) GAACA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160278375-A1 BISCATIONIC AND TRISCATIONIC AMPHIPHILES AS ANTIMICROBIAL AGENTS TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-09-29 US disclosed
EP-3065547-A1 BISCATIONIC AND TRISCATIONIC AMPHILES AS ANTIMICROBIAL AGENTS Temple University Of The Commonwealth System Of Higher Education (US) 2016-09-14 EP disclosed
WO-2015069760-A1 BISCATIONIC AND TRISCATIONIC AMPHILES AS ANTIMICROBIAL AGENTS TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2015-05-14 WO disclosed
EP-1628685-A2 ANTIVIRAL PHOSPHONATE ANALOGS GILEAD SCIENCES, INC. (US) 2006-03-01 EP disclosed
WO-2004096286-A2 ANTIVIRAL PHOSPHONATE ANALOGS GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed
US-4748272-A Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways RORER PHARMACEUTICAL CORP. (US) 1988-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160278375-A1 BISCATIONIC AND TRISCATIONIC AMPHIPHILES AS ANTIMICROBIAL AGENTS PYM1, C5, C1S GAA 3763/4885CA1 3386/4885CA2 2570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.